Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,786 | 204 | 90.0% |
| Education | $422.46 | 8 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $337.87 | 17 | $0 (2024) |
| Seagen Inc. | $317.84 | 12 | $0 (2023) |
| Merck Sharp & Dohme LLC | $270.00 | 14 | $0 (2024) |
| PFIZER INC. | $253.28 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $246.54 | 11 | $0 (2024) |
| Amgen Inc. | $235.42 | 13 | $0 (2023) |
| Lilly USA, LLC | $195.16 | 12 | $0 (2024) |
| Incyte Corporation | $189.39 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $162.35 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $160.58 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $820.42 | 39 | Novartis Pharmaceuticals Corporation ($143.68) |
| 2023 | $888.26 | 40 | Seagen Inc. ($237.88) |
| 2022 | $708.47 | 35 | SANOFI-AVENTIS U.S. LLC ($99.99) |
| 2021 | $623.69 | 29 | Janssen Biotech, Inc. ($129.49) |
| 2020 | $157.79 | 9 | Amgen Inc. ($73.07) |
| 2019 | $132.21 | 9 | Merck Sharp & Dohme Corporation ($29.85) |
| 2018 | $37.42 | 3 | Janssen Biotech, Inc. ($37.42) |
| 2017 | $840.22 | 48 | Millennium Pharmaceuticals, Inc. ($119.56) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $30.95 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/16/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Oncology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Oncology | ||||||
| 10/24/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $20.04 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/05/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $41.28 | General |
| Category: BioOncology | ||||||
| 08/22/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.31 | General |
| Category: Hematology/Oncology | ||||||
| 08/20/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Oncology | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: Oncology | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Oncology | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.56 | General |
| 06/27/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 15 | $2,850 | $1,158 |
| 2022 | 1 | 19 | 32 | $6,080 | $1,966 |
| 2020 | 1 | 17 | 27 | $4,752 | $2,148 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 15 | $2,850 | $1,158 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 32 | $6,080 | $1,966 | 32.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 27 | $4,752 | $2,148 | 45.2% |
About Dr. Rolando Breier, MD
Dr. Rolando Breier, MD is a Hematology & Oncology healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1033379938.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rolando Breier, MD has received a total of $4,208 in payments from pharmaceutical and medical device companies, with $820.42 received in 2024. These payments were reported across 212 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($3,786).
As a Medicare-enrolled provider, Breier has provided services to 48 Medicare beneficiaries, totaling 74 services with total Medicare billing of $5,272. Data is available for 3 years (2020–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Jefferson City, MO
- Active Since 06/13/2008
- Last Updated 01/10/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1033379938
Products in Payments
- KEYTRUDA (Biological) $238.79
- IMBRUVICA (Drug) $210.84
- Lenvima (Drug) $128.16
- JAKAFI (Drug) $120.48
- LIBTAYO (Biological) $114.01
- FOUNDATIONONE (Device) $112.40
- Xermelo (Drug) $107.46
- TUKYSA (Drug) $103.88
- ELITEK (Biological) $99.99
- OPDIVO (Biological) $89.36
- CYRAMZA (Drug) $81.17
- AYVAKIT (Drug) $76.81
- BOSULIF (Drug) $71.45
- MEKINIST (Drug) $69.54
- VERZENIO (Drug) $67.42
- LUTATHERA (Drug) $62.87
- INLYTA (Drug) $61.23
- KISQALI (Drug) $60.99
- SARCLISA (Biological) $59.85
- Nplate (Biological) $59.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Jefferson City
Shadi Haddadin, Md, MD
Hematology & Oncology — Payments: $50,117
Dr. Ali Khojasteh, M.d, M.D
Hematology & Oncology — Payments: $27,148
Dr. Tamara Hopkins, M.d, M.D
Hematology & Oncology — Payments: $7,839
Dr. John Savooji, Md, MD
Hematology & Oncology — Payments: $4,207
Joseph Doggett, D.o, D.O
Hematology & Oncology — Payments: $30.59